Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.
Swiss drugmaker Novartis AG said Tuesday it will eliminate 1,400 U.S. sales jobs by Jan. 1.
The company said it will cut the jobs from the sales force of its general medicines business, as sales at that business will be hurt after the patent on its high blood pressure drug Diovan expires. Novartis said it plans to focus more resources on its primary care and specialty care businesses.
Drug and medical device firm Abbott Laboratories says it has abandoned plans to sell its vaccines unit, less than three months after exploring sales talks with rival companies. Get the full story »
From the Chicago Daily Herald | Abbott Labs has settled a patent infringement suit against Sandoz over generic versions of the antibiotic Omnicef. Terms were not disclosed.
